Sign in
Active, not recruitingNo phase

Myopia Control Efficacy of Second-generation DIMS Spectacle Lenses on Fast Progressing Myopes

Key facts

Who runs it
The Hong Kong Polytechnic University
Where
Hong Kong1 site in 1 countryChoose a country to see its sites
Trial code
Status
Active, not recruiting
People taking part
118 people, planned
Started
29 Jul 2023
Expected to end
31 Dec 2028
Type of study
Interventional, 2 groupsOne group gets no study treatment, for comparison.
Treatments tested
  • Variant of Defocus Incorporated Spectacle lens (DG2)
Record updated
22 April 2026

Who can take part

Age
4 years to 12 years
Sex
Women and men
Healthy volunteers
Can take part

The registry criteria, word for word

Show all 9 criteriaShow less

Who can take part

  • SER: -0.75D or below in both eyes
  • Documented history of fast progressing myopia, either in SER or AL; SER progression: 0.50D/year or more; AL elongation: 0.27mm/year or more; For children aged 4-6 years without past prescription forms,; 4-5 years old: myopia of -0.75D or below in both eyes; 6 years old: myopia of -1.25D or below in at least one eye, with the other eye -0.75D or below
  • Best-corrected visual acuity (VA) in both eyes:; 4 - 6 years old: 0.20 logMAR (or its equivalent) or better; 7-12 years old: 0.00 logMAR (or its equivalent) or better
  • Acceptance of random group allocation and the masked study design
  • Anisometropia of 1.50 D or less
  • Astigmatism of 2.00 D or less

Who cannot take part

  • Prior experience of myopia control
  • Strabismus and binocular vision abnormalities
  • Ocular and systemic abnormalities

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The purpose of this study is to examine the efficacy and performance of the variant of Defocus Incorporated Spectacle lenses on controlling myopia progression in fast progressing myopic children.

The 2 groups in the trial

  • Single vision lens groupNo study treatment, for comparison

    Subjects in single vision lens group will receive a pair of single vision lenses for the first year of study. They will then receive a pair of DG2 lenses for an additional 3 years.

  • D2 lens groupTreatment being tested

    Subjects in D2 lens group will receive a pair of D2 lenses over the 4-year study.

    Treatment: Variant of Defocus Incorporated Spectacle lens (DG2)

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Myopia Control Effectiveness of Second-generation Defocus Incorporated Multiple Segments Spectacle Lenses on Fast Progressing Myopes: A Randomized Controlled Trial
Publications
Record updated
22 April 2026